Immune responses to AAV capsid: are mice not humans after all?
about
Therapeutic application of RNAi: is mRNA targeting finally ready for prime time?Gene therapy for hemophiliaIn vitro and in vivo gene therapy vector evolution via multispecies interbreeding and retargeting of adeno-associated viruses.AAV provides an alternative for gene therapy of the peripheral sensory nervous system.Characterization of naturally-occurring humoral immunity to AAV in sheep.Analysis of transduction efficiency, tropism and axonal transport of AAV serotypes 1, 2, 5, 6, 8 and 9 in the mouse brain.An AAV9 coding for frataxin clearly improved the symptoms and prolonged the life of Friedreich ataxia mouse modelsAn Immune-Competent Murine Model to Study Elimination of AAV-Transduced Hepatocytes by Capsid-Specific CD8+ T CellsImmune responses to adenovirus and adeno-associated vectors used for gene therapy of brain diseases: the role of immunological synapses in understanding the cell biology of neuroimmune interactionsSurface loop dynamics in adeno-associated virus capsid assembly.Engineered AAV vector minimizes in vivo targeting of transduced hepatocytes by capsid-specific CD8+ T cells.Distinct immune responses to transgene products from rAAV1 and rAAV8 vectorsAn analysis of retinal gene therapy clinical trials.Targeted gene therapy for the treatment of heart failure.Manipulating Immune Tolerance with Micro-RNA Regulated Gene Therapy.Trophic factor gene therapy for Parkinson's disease.Recent Developments in Gene Therapy for Homozygous Familial Hypercholesterolemia.Liver-Directed Adeno-Associated Viral Gene Therapy for Hemophilia.Herpes simplex virus type 1/adeno-associated virus hybrid vectors.AAV vector biology in primates: finding the missing link?Myocarditis following adeno-associated viral gene expression of human soluble TNF receptor (TNFRII-Fc) in baboon hearts.Regulatory and Scientific Advancements in Gene Therapy: State-of-the-Art of Clinical Applications and of the Supporting European Regulatory Framework.Parvoviruses: structure and infection
P2860
Q24669624-C69C374D-931F-4816-89E6-7B05E614B67EQ28081911-DA6C196E-3CC1-40E2-8B46-3FC784E70ECAQ33327474-6EA57A5F-6599-46AF-9E32-EF7D703FA4DFQ33822179-B4184554-1532-445C-9453-56A0C6107AB0Q35005408-DEBB7BE2-3194-4E32-A054-116BF16F9E11Q35006292-77399542-F650-4AB0-A095-3358FE95102AQ35184184-6DA1AA5A-D580-4795-96B9-B0D2648F5759Q36365372-E0EFD452-B98C-486A-9143-3E6001DD6385Q36498773-E01F757A-9707-445B-9BAB-9A223F52F1EDQ36673382-CE530289-16DE-49BB-8A97-B8AB82E7C334Q36709834-36EE270F-B440-48E5-B762-06B11EB15A03Q37385999-853FD976-7EC4-4BE7-928B-E069F7E1FB99Q37608996-2B02ED48-C26D-4F4A-8BA1-920F1C0266BAQ37878086-6C4DFC2B-8F9B-4931-AB72-893C5BE5DD8DQ37965158-8965E599-1D7C-487F-84BE-4F24F004EE42Q38079792-ABD159B9-BE1B-45E9-9DC8-5BCFDAA6C380Q38776037-BF7FE5AA-0CF6-42C3-93D1-F328CDE26434Q39553052-C7842D05-DE92-4D0D-9D29-6ACF4826CA0BQ42448457-26711375-EC7D-4C18-8DC7-ABEA469FB39DQ42976432-DF9A73AB-280E-4992-A36D-C2E53F56DEDFQ45871000-17E8A2BE-F95C-4F5A-B71F-6B413E0FBDDAQ45874266-2E7AB47F-6B6A-4760-85E8-C37C571564C8Q56115905-EF9E6465-E1F1-4426-8163-B20324389C02
P2860
Immune responses to AAV capsid: are mice not humans after all?
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
2007年學術文章
@zh-hant
name
Immune responses to AAV capsid: are mice not humans after all?
@en
Immune responses to AAV capsid: are mice not humans after all?
@nl
type
label
Immune responses to AAV capsid: are mice not humans after all?
@en
Immune responses to AAV capsid: are mice not humans after all?
@nl
prefLabel
Immune responses to AAV capsid: are mice not humans after all?
@en
Immune responses to AAV capsid: are mice not humans after all?
@nl
P356
P1433
P1476
Immune responses to AAV capsid: are mice not humans after all?
@en
P2093
Roland W Herzog
P304
P356
10.1038/SJ.MT.6300123
P577
2007-04-01T00:00:00Z